DNA X, Inc.
SONM· Nasdaq
SONMDNA X, Inc.
Filed Mar 18, 2021 · 10-K · 77 days after period end · 0001564590-21-014012
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|
| Revenue | $15.84M | $17.17M | $46.53M |
| Net Income | -$6.41M | -$6.78M | $4.34M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 18, 2021 · 77 d after period end
